News and Blog
Welcome to your information hub to keep up to date with our latest news, product launches, industry insights, case studies and much more.
View all blogs:
Partnership agreement between Croda and AAHI to drive innovation in vaccine development
19 March 2024: Croda International Plc (Croda) and The Access to Advanced Health Institute (AAHI) are pleased to announce today the signing of a partnership agreement around innovation and development...
Lea más
Croda Foundation announces it has sustainably improved the lives of 22.8 million people – exceeding its 2030 target.
Croda Foundation announces it has sustainably improved the lives of 22.8 million people –exceeding its 2030 target.
Lea más
Specializing in specific enhancement technologies
Croda Pharma specializes in four technologies aimed at improving bioavailability and solubility. Find out more!
Lea más
Concerns about Triton™ X-100 have been an ongoing discussion across multiple regulatory authorities around the world
Triton™ X-100, a non-ionic surfactant with a hydrophilic polyethylene oxide chain and a hydrophobic aromatic group1, has found widespread use in the biopharmaceutical industry with applications...
Lea más
“Close the Care Gap” – World Cancer Day 2024
We are proud to continue supporting the development of cancer treatments, and on this World Cancer Day, recognise the importance of innovation and science to cure and treat those diagnosed. Together,...
Lea más
Spotlight on Kritika Bajaj
Highlighting the scientists and teams who are involved in our latest product launch, Virodex™, replacements for Triton™ X-100, we sat down with Kritika Bajaj and asked her about her involvement around...
Lea más
Croda’s response to Sustainable Markets Initiative for supplier sustainability targets
The recent open letter from the Sustainable Markets Initiative Health Systems Task Force called for Healthcare supply chains to become greener, more efficient and circular and set out a series of...
Lea más
Sustainability for vaccines: Decarbonisation of one of our key sites
Sustainability is often defined as meeting the needs of those alive today without compromising the ability of future generations to meet their needs. It is a long-term goal that covers three pillars:...
Lea más
A powerful match - celebrating three years of Croda Pharma and Avanti
Today marks three years since we acquired Avanti Polar Lipids. During the COVID-19 pandemic, it became clear that the combination of Avanti's lipid expertise and our manufacturing scale-up capability...
Lea más
Introducing new bioprocessing solutions to replace banned materials
We have introduced a critical range of new bioprocessing detergents optimised for viral inactivation and cell lysis. The company’s new product range, Virodex™, offers an answer to the key market need...
Lea más
Cholesterol: enhancing stability and efficacy in lipid-based drug delivery
Cholesterol, a key component in lipid-based drug delivery systems, provides structural support and stability, enhances the efficiency of intracellular delivery and gene transfection.
Lea más
Acquisition of Solus Biotech expands specialised Pharma business in Asia
05 July 2023: Croda International Plc (‘Croda’) announced that it has acquired Solus Biotech, a global leader in premium, biotechnology-derived materials, from Solus Advanced Materials
Lea más
Acquisition of Solus Biotech strengthens Croda Pharma
On 04 July Croda successfully completed the acquisition of Solus Biotech, an innovative biotechnology company with over three decades of industry experience.
Lea más
Croda opens new Global Technical Centre at Genome Valley, Hyderabad, India
PRESS RELEASE – On June 21, 2023, Croda International Plc opened its new Global Technical Centre at Genome Valley, Hyderabad, India.
Lea más
Croda breaks ground on new manufacturing facility for pharmaceutical excipients in Lamar, Pennsylvania
31st May 2023: Croda, Inc., the company that uses smart science to create high-performance ingredients and solutions that improve lives, broke ground on 9 May 2023, its newest manufacturing facility...
Lea más
From Triton X-100 to Virodex: exploring our innovative solution to the Triton X-100 ban
For those who have previously relied on Triton™ X-100 as a surfactant or detergent in their manufacturing processes there is now an urgent need to find a suitable replacement. Explore Croda's...
Lea más
Croda announces two new partnerships to drive sustainable delivery systems for the pharmaceutical industry
19 May 2023: Croda International Plc (Croda) today announced that it has signed two new partnership agreements that will help the pharmaceutical industry move towards a more sustainable supply chain...
Lea más
Oral Drug Delivery
The oral route of administration presents a convenient, cost-effective, and non-invasive method for delivering drugs. However, with the increasing complexity of APIs, the delivery of these drugs also...
Lea más
The future of mRNA delivery: Advancements in engineering lipid nanoparticles for enhanced intracellular delivery through inhalation
Messenger RNA (mRNA) has played a crucial role in recent vaccine developments and is at the forefront of much current medical research. Traditionally. the delivery of mRNA systemically via lipid...
Lea más
Revolutionizing gene editing: How RGD peptide-based lipids could be the key to effective mRNA delivery
Gene editing has emerged as a promising strategy for treating a wide range of genetic disorders. However, the efficacy of gene therapy is limited by the challenge of delivering therapeutic agents to...
Lea más
Lets connect...
Register to the mailing list to unlock:
- First access to new products, new data and exclusive literature
- Whitepapers and thought provoking content
- Special offers on conference and exhibition passes when available
- Invitations to invite only Croda Pharma events.